Our documents
Find the publications of the association’s working groups
Reuse of RWE data in Decentralized Clinical Trials
While totally decentralized and dematerialized studies are not yet possible in France, there are solutions to get closer to this goal while we wait for the regulations to change.
Early acces pathway in France: all you want to know
Clinical Research in France - Key figures
France remains one of the European leaders in clinical research in 2022.
Despite a slight drop in research activity in 2022, France remains positioned as a leader in the initiation of clinical studies in Europe ahead of Spain and UK. In terms of industrial trials, France is behind Spain and is almost on par with Germany.
AFCROs whitepaper | Decentralized clinical trials: from words to action
Based on feedback, interviews with various stakeholders, and the views of
different actors in the care of patients, this white paper aims to determine the
optimal conditions for carrying out a hybrid decentralized clinical study in the
home.
25 October 2022
13th July 2022
AFCROs Guide to the appropriate use of data from the National Health Data System (SNDS)
The RWD working group of AFCROs, which brings together expert consultancy firms, presents the first practical guide integrating the whole circuit of data feedback in the SNDS as well as some recommendations on the most relevant way to use them.
8th July 2021
Why France for clinical research
The association’s attractiveness group offers you a few key points on why you should choose France for your clinical trials